- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06240312
Optic Nerve Head Strain as Biomarker for Glaucoma
June 11, 2025 updated by: Johns Hopkins University
The investigators will test the hypothesis that images of the optic nerve head taken a 2 different eye pressures will yield strain estimates that are predictive of the course of glaucoma.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Existing glaucoma patients and suitable control adults will be imaged with an FDA-approved optical coherence tomography instrument.
Those who are imaged at 2 different eye pressures will generate biomechanical strain estimates.
These will be compared to visual field and retinal nerve fiber layer measurements over time.
The investigators expect that baseline strain and their changes over time will be associated with progression rate of glaucoma damage, providing a biomarker for susceptibility.
Study Type
Interventional
Enrollment (Estimated)
130
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Harry A Quigley
- Phone Number: 4109556051
- Email: hquigley@jhmi.edu
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Recruiting
- Johns Hopkins University
-
Contact:
- Harry A Quigley, MD
- Phone Number: 410-955-6052
- Email: hquigley@jhmi.edu
-
Contact:
- Solanyi Moronta, AB
- Phone Number: 4109556051
- Email: smoront1@jhmi.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Existing glaucoma patients of Johns Hopkins
Exclusion Criteria:
- Inability to perform imaging
- illiterate
- hearing impaired
- non-English speakers
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: All subjects
Each subject will be imaged at two different times and eye pressures
|
subject images of the eye's optic nerve head are studied
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Optic nerve head mechanical strain compared to visual field change over time
Time Frame: Approximately 3 years
|
Strains measured at baseline are tested for association with glaucoma course
|
Approximately 3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Harry Quigley, Johns Hopkins School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2024
Primary Completion (Estimated)
January 31, 2028
Study Completion (Estimated)
January 31, 2028
Study Registration Dates
First Submitted
January 26, 2024
First Submitted That Met QC Criteria
February 2, 2024
First Posted (Actual)
February 5, 2024
Study Record Updates
Last Update Posted (Actual)
June 15, 2025
Last Update Submitted That Met QC Criteria
June 11, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00431247
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glaucoma, Open-Angle
-
Henry Ford Health SystemNot yet recruitingPrimary Open Angle Glaucoma (POAG) | Secondary Open Angle Glaucoma | Open Angle Glaucoma (OAG)United States
-
Glostrup University Hospital, CopenhagenRecruitingGlaucoma | Open-Angle Glaucoma | Primary Open Angle Glaucoma (POAG)Denmark
-
Omar SaidCompletedGlaucoma,Primary Open-Angle ,Primary Angle ClosureEgypt
-
Perfuse Therapeutics, Inc.Completed
-
Sight Sciences, Inc.TerminatedOpen-Angle GlaucomaUnited States
-
Glaukos CorporationCompletedGlaucoma Open-angleUnited States
-
Glaukos CorporationCompleted
-
Glaukos CorporationCompleted
-
Wroclaw Medical UniversityWrocław University of Science and TechnologyActive, not recruitingOpen-angle GlaucomaPoland
Clinical Trials on Images of eye at 2 eye pressures
-
Fondation Ophtalmologique Adolphe de RothschildJohnson & JohnsonTerminated
-
Zhu ZijianNot yet recruitingPost-Traumatic Stress Disorder (PTSD) | Intrusive Memories of Traumatic Event(s)
-
Yu-Hsin HsiehChang Gung University; Jonkoping University; Folke Bernadotte Stiftelsen; Stiftelsen... and other collaboratorsCompletedCommunication Disorders | Self-Help Devices | Eye-Gaze Technology | Severe Physical DisabilitiesSweden
-
Hospital El CruceCompletedVentilation, MechanicalArgentina
-
Erasmus Medical CenterRecruitingColorectal PolypsNetherlands
-
Korea University Anam HospitalKukje PharmaCompletedDry Eye Disease (DED)South Korea
-
Debbie S. Kuo, MDAlcon ResearchActive, not recruitingAphakia, PostcataractUnited States
-
Clinique Victor PauchetRecruiting
-
Pleryon Therapeutics (Hangzhou) LimitedUniversity of Waterloo School of Optometry and Vision ScienceRecruiting
-
Bitop AGCompletedEye ManifestationsGermany